Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, Parkin DM, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru YW, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F; SURVCAN-3 collaborators.
Soerjomataram I, et al. Among authors: miranda filho a.
Lancet Oncol. 2023 Jan;24(1):22-32. doi: 10.1016/S1470-2045(22)00704-5.
Lancet Oncol. 2023.
PMID: 36603919